Triple-negative breast cancer (TNBC) is immunohistochemically characterized by negative expression of estrogen receptors (ER), progesterone receptors (PR), and HER2 and often a basal-like breast cancer (BLBC) [5,6,7]. Here, ESR1 is linked to triple-negative breast carcinoma.